Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangling Gel is a traditional Chinese medicine (TCM) topical formulation developed by Shandong Hanfang Pharmaceutical for the treatment of uncomplicated vulvovaginal candidiasis (VVC). It is specifically indicated for patients presenting with the damp-heat downward flow syndrome, a TCM diagnostic pattern associated with inflammatory vaginal conditions. The drug is currently in Phase II clinical development (e.g., trial CTR20260702), where it is being evaluated for efficacy and safety in a randomized, double-blind, placebo-controlled setting. As a botanical product, its therapeutic effect is derived from a combination of herbal extracts known for their antimicrobial and anti-inflammatory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangling Gel.